This post is by Global Center Director Christine Lubinski, who is attending the Conference on Opportunistic Infections and Retroviruses (CROI) this week in San Francisco. This is her first post; check back regularly for her blogs throughout the conference. The opening plenary of this leading HIV scientific conference—titled “Guiding the Global Response”—highlighted efforts to model the […]
There’s fresh evidence out today that greater access to AIDS treatment for women will help keep their babies healthy. A new article in Clinical Infectious Diseases reports that a higher maternal viral load during the 30th week of pregnancy significantly increased the risk of HIV transmission to the baby—a finding that provides additional confirmation of […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]